178 related articles for article (PubMed ID: 37906960)
1. Engineered Recombinant EGFP-Azurin Theranostic Nanosystem for Targeted Therapy of Prostate Cancer.
Bhardwaj R; Mishra P
Mol Pharm; 2023 Dec; 20(12):6066-6078. PubMed ID: 37906960
[TBL] [Abstract][Full Text] [Related]
2. The role of ephrins and Eph receptors in cancer.
Surawska H; Ma PC; Salgia R
Cytokine Growth Factor Rev; 2004 Dec; 15(6):419-33. PubMed ID: 15561600
[TBL] [Abstract][Full Text] [Related]
3. Eph receptors and ephrins as targets for cancer therapy.
Xi HQ; Wu XS; Wei B; Chen L
J Cell Mol Med; 2012 Dec; 16(12):2894-909. PubMed ID: 22862837
[TBL] [Abstract][Full Text] [Related]
4. Potential clinical relevance of Eph receptors and ephrin ligands expressed in prostate carcinoma cell lines.
Fox BP; Tabone CJ; Kandpal RP
Biochem Biophys Res Commun; 2006 Apr; 342(4):1263-72. PubMed ID: 16516143
[TBL] [Abstract][Full Text] [Related]
5. Ectodomain structures of Eph receptors.
Himanen JP
Semin Cell Dev Biol; 2012 Feb; 23(1):35-42. PubMed ID: 22044883
[TBL] [Abstract][Full Text] [Related]
6. EphA6 promotes angiogenesis and prostate cancer metastasis and is associated with human prostate cancer progression.
Li S; Ma Y; Xie C; Wu Z; Kang Z; Fang Z; Su B; Guan M
Oncotarget; 2015 Sep; 6(26):22587-97. PubMed ID: 26041887
[TBL] [Abstract][Full Text] [Related]
7. The first identification of complete Eph-ephrin signalling in ctenophores and sponges reveals a role for neofunctionalization in the emergence of signalling domains.
Krishnan A; Degnan BM; Degnan SM
BMC Evol Biol; 2019 Apr; 19(1):96. PubMed ID: 31023220
[TBL] [Abstract][Full Text] [Related]
8. Eph receptors and ephrins.
Himanen JP; Nikolov DB
Int J Biochem Cell Biol; 2003 Feb; 35(2):130-4. PubMed ID: 12479863
[TBL] [Abstract][Full Text] [Related]
9. The Functions of EphA1 Receptor Tyrosine Kinase in Several Tumors.
Wu Y; Du Z; Mou J; Qiu X; Chen J; Cai S; Ren D; Xiao F; Zhou G; Yuan C
Curr Med Chem; 2023; 30(20):2340-2353. PubMed ID: 35996244
[TBL] [Abstract][Full Text] [Related]
10. Signals transduced by Eph receptors and ephrin ligands converge on MAP kinase and AKT pathways in human cancers.
Lau A; Le N; Nguyen C; Kandpal RP
Cell Signal; 2023 Apr; 104():110579. PubMed ID: 36572189
[TBL] [Abstract][Full Text] [Related]
11. Eph/ephrin recognition and the role of Eph/ephrin clusters in signaling initiation.
Nikolov DB; Xu K; Himanen JP
Biochim Biophys Acta; 2013 Oct; 1834(10):2160-5. PubMed ID: 23628727
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of eph receptor kinase activation in cancer cells by coexpressed ephrin ligands.
Falivelli G; Lisabeth EM; Rubio de la Torre E; Perez-Tenorio G; Tosato G; Salvucci O; Pasquale EB
PLoS One; 2013; 8(11):e81445. PubMed ID: 24348920
[TBL] [Abstract][Full Text] [Related]
13. Cupredoxin-cancer interrelationship: azurin binding with EphB2, interference in EphB2 tyrosine phosphorylation, and inhibition of cancer growth.
Chaudhari A; Mahfouz M; Fialho AM; Yamada T; Granja AT; Zhu Y; Hashimoto W; Schlarb-Ridley B; Cho W; Das Gupta TK; Chakrabarty AM
Biochemistry; 2007 Feb; 46(7):1799-810. PubMed ID: 17249693
[TBL] [Abstract][Full Text] [Related]
14. Artesunate-induced Cellular Effects Are Mediated by Specific EPH Receptors and Ephrin Ligands in Breast Carcinoma Cells.
Zadeh T; Lucero M; Kandpal RP
Cancer Genomics Proteomics; 2022; 19(1):19-26. PubMed ID: 34949656
[TBL] [Abstract][Full Text] [Related]
15. Eph receptors and ephrins: therapeutic opportunities.
Barquilla A; Pasquale EB
Annu Rev Pharmacol Toxicol; 2015; 55():465-87. PubMed ID: 25292427
[TBL] [Abstract][Full Text] [Related]
16. Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation.
Giorgio C; Hassan Mohamed I; Flammini L; Barocelli E; Incerti M; Lodola A; Tognolini M
PLoS One; 2011 Mar; 6(3):e18128. PubMed ID: 21479221
[TBL] [Abstract][Full Text] [Related]
17. Regulation and misregulation of Eph/ephrin expression.
Arvanitis DN; Davy A
Cell Adh Migr; 2012; 6(2):131-7. PubMed ID: 22568953
[TBL] [Abstract][Full Text] [Related]
18. Cancer cells exploit the Eph-ephrin system to promote invasion and metastasis: tales of unwitting partners.
Wang B
Sci Signal; 2011 May; 4(175):pe28. PubMed ID: 21632467
[TBL] [Abstract][Full Text] [Related]
19. Eph signaling: a structural view.
Himanen JP; Nikolov DB
Trends Neurosci; 2003 Jan; 26(1):46-51. PubMed ID: 12495863
[TBL] [Abstract][Full Text] [Related]
20. Eph receptor tyrosine kinases in cancer stem cells.
Chen J; Song W; Amato K
Cytokine Growth Factor Rev; 2015 Feb; 26(1):1-6. PubMed ID: 24933439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
